ΒAUSCH + LOMB Greece is a multinational pharmaceutical company that manufactures a broad range of branded pharmaceuticals, over-the-counter (OTC) products and medical devices. Founded in 1853, we have significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. We have a diversified portfolio of products, with a core focus in the areas of Eye Health and General Health. In Greece, some of the most reputable products are Biotrue®, Renu®, Niflamol®, Counterpain®, Ezixin®, Ocuvite®, Vidilac®, Artelac® & Dexamytrex®. Every day, our products are trusted by 150 million people globally. In BAUSCH + LOMB, our mission is to help people see better and live better all over the world—that’s why we started and what we still strive for today. Through unwavering focus rooted in innovation, quality and craftsmanship, we continue to pursue our lifelong vision of protecting and enhancing the gift of sight through every phase of life. In April 2018, BAUSCH + LOMB became the first pharmaceutical company in Europe to be certified with ISO 37001 in anti-bribery management systems. Most importantly, BAUSCH + LOMB Greece is a Great Place to Work® Hellas winning company, with a 3rd Best Workplaces 2022 award, in the category of companies with 50-250 employees.
